Xiaolong Wei

3.1k total citations
82 papers, 2.3k citations indexed

About

Xiaolong Wei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaolong Wei has authored 82 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 21 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Xiaolong Wei's work include Cancer Cells and Metastasis (11 papers), Cancer-related gene regulation (8 papers) and RNA Research and Splicing (8 papers). Xiaolong Wei is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Cancer-related gene regulation (8 papers) and RNA Research and Splicing (8 papers). Xiaolong Wei collaborates with scholars based in China, United States and Netherlands. Xiaolong Wei's co-authors include Donald Küfe, Haiyan Xu, Guo‐Jun Zhang, Wen-Jia Chen, Jing‐Wen Bai, Jiekun Yang, Mazhar Adli, Chunfa Chen, Cem Kuscu and Yuanke Liang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Xiaolong Wei

78 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolong Wei China 26 1.6k 680 496 208 200 82 2.3k
Yuqing Chen China 26 1.4k 0.9× 783 1.2× 326 0.7× 165 0.8× 286 1.4× 80 2.1k
Laurent Poulain France 29 1.6k 1.0× 869 1.3× 645 1.3× 161 0.8× 152 0.8× 79 2.6k
Éric Hervouet France 27 1.7k 1.1× 602 0.9× 416 0.8× 238 1.1× 215 1.1× 54 2.4k
Lijun Di China 25 1.0k 0.7× 389 0.6× 602 1.2× 236 1.1× 180 0.9× 102 1.9k
Carmen de Torres Spain 26 1.2k 0.8× 505 0.7× 383 0.8× 165 0.8× 194 1.0× 64 2.4k
Wenhong Fan United States 31 1.6k 1.0× 602 0.9× 547 1.1× 252 1.2× 258 1.3× 69 2.8k
Yu-Ru Lee Taiwan 17 1.4k 0.9× 444 0.7× 344 0.7× 166 0.8× 134 0.7× 31 1.8k
Peng Shen China 24 1.3k 0.9× 773 1.1× 482 1.0× 136 0.7× 483 2.4× 71 2.1k
Jen-Liang Su Taiwan 27 1.8k 1.2× 780 1.1× 863 1.7× 275 1.3× 165 0.8× 35 2.5k

Countries citing papers authored by Xiaolong Wei

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Wei more than expected).

Fields of papers citing papers by Xiaolong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Wei. The network helps show where Xiaolong Wei may publish in the future.

Co-authorship network of co-authors of Xiaolong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Wei. A scholar is included among the top collaborators of Xiaolong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Wei. Xiaolong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Tao, G. M. Huang, Xiaolong Wei, et al.. (2025). Pincer‐Type Pt(II)‐NHC Antibody‐Drug Conjugate for HER‐2‐Targeted Chemoimmunotherapy. Advanced Healthcare Materials. 14(9). e2403449–e2403449. 1 indexed citations
2.
Wei, Xiaolong, et al.. (2024). Adsorption performance and mechanism of waste paper-derived phosphorus-rich carbon for separation of uranium from radioactive wastewater. Journal of environmental chemical engineering. 12(2). 112486–112486. 21 indexed citations
4.
Wei, Xiaolong, Lucas Carter, Jiekun Yang, et al.. (2024). Depletion of lamins B1 and B2 promotes chromatin mobility and induces differential gene expression by a mesoscale-motion-dependent mechanism. Genome biology. 25(1). 77–77. 16 indexed citations
5.
6.
Wang, Bingqian, et al.. (2024). Efficacy and safety of botulinum neurotoxin in the treatment of hemifacial spasms: a systematic review and meta-analysis. BMC Neurology. 24(1). 420–420. 4 indexed citations
7.
Wu, Yuanyuan, Zhiwei Li, Jingwen Yang, et al.. (2023). Preparation of lactosucrose catalyzed by levansucrase and evaluation of its prebiotic activity. Process Biochemistry. 134. 76–87. 6 indexed citations
8.
Wei, Min, Hong Chen, Zhong Luo, et al.. (2023). Methylation of ESR1 promoter induced by SNAI2–DNMT3B complex promotes epithelial–mesenchymal transition and correlates with poor prognosis in ERα‐positive breast cancers. SHILAP Revista de lepidopterología. 4(6). e403–e403. 7 indexed citations
9.
Liu, Zhan, et al.. (2023). Performance of compressed CO2 energy storage systems with different liquefaction and storage scenarios. Fuel. 359. 130527–130527. 21 indexed citations
10.
Liang, Yuanke, Xiaoling Zhou, Qin Xie, et al.. (2022). CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells. Cancer Letters. 546. 215856–215856. 23 indexed citations
11.
Chen, Jianzhou, et al.. (2021). Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy. Clinical Cancer Research. 27(14). 3990–4002. 16 indexed citations
12.
Zhang, Yong‐Qu, Yuanke Liang, Yang Wu, et al.. (2021). Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN. Cell Death and Disease. 12(6). 502–502. 34 indexed citations
13.
Zhang, Yong‐Qu, et al.. (2021). Co-expression of VEGF-C and survivin predicts poor prognosis in esophageal squamous cell carcinoma. Translational Cancer Research. 10(1). 210–222. 6 indexed citations
14.
Wei, Xiaolong, Jiekun Yang, Sara J. Adair, et al.. (2020). Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells. Proceedings of the National Academy of Sciences. 117(45). 28068–28079. 60 indexed citations
15.
Cheng, Yu-Hong, Chun‐Nam Lok, Ho Yu Au‐Yeung, et al.. (2020). Surface optimization of gold nanoparticle mass tags for the sensitive detection of protein biomarkers via immuno-capture LI-MS. The Analyst. 145(19). 6237–6242. 13 indexed citations
16.
Xu, Jianzhen, Changchun Shao, Xiaojia Wang, et al.. (2019). circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death and Disease. 10(3). 175–175. 205 indexed citations
17.
Dou, Xiaowei, Yuanke Liang, Haoyu Lin, et al.. (2017). Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α. Theranostics. 7(16). 4041–4056. 50 indexed citations
18.
Chen, Wen-Jia, Caiwen Du, Si-Qi Qiu, et al.. (2014). Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China. Scientific Reports. 4(1). 5360–5360. 18 indexed citations
19.
Wei, Xiaolong, Haiyan Xu, & Donald Küfe. (2007). Human Mucin 1 Oncoprotein Represses Transcription of the p53 Tumor Suppressor Gene. Cancer Research. 67(4). 1853–1858. 84 indexed citations
20.
Wei, Xiaolong, Haiyan Xu, & Donald Küfe. (2006). MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α. Molecular Cell. 21(2). 295–305. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026